Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Bogle replaces Bazemore as CEO at Epizyme

Plus: Updates from AltruBio, Sutro, Rheos, Affinivax and more

By Gunjan Ohri, Data Content Analyst
August 10, 2021 2:04 AM UTC

Robert Bazemore will step down as president and CEO of Epizyme Inc. (NASDAQ:EPZM) and continue as an adviser to the company. Bazemore will be succeeded by board member Grant Bogle, who previously served as SVP and chief commercial officer at Tesaro Inc., which GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) acquired in 2019. 

Immunology play AltruBio Inc. hired Jeroen Grasman as CFO. Grasman joins from Pact Pharma Inc. where he was VP of finance and operations...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Affinivax Inc.

Altrubio Inc.

Epizyme Inc.

Immunometabolism Newco Inc.

Imvax Inc.

Sutro Biopharma Inc.